Clair, a startup founded by Stanford graduates, is developing a wearable hormone-tracking device to improve how women access and understand their hormonal health. The company, started by Jenny Duan ...

Diabetes is incredibly common. According to the American Diabetes Association, around 7 million people in the United States are undiagnosed, with 1 in 3 Americans at risk for developing type 2 ...

Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by aging populations, staffing shortages, and a push toward data-driven care ...

Researchers at the University of California, Irvine have developed a multimodal, bioelectronic wrist-worn device for objective, continuous, real-time monitoring of stress. The Smart Quantitative and ...

Dear Dr. Roach: I am a 75-year-old man with an elevated A1C level; I was diagnosed with prediabetes. I feel healthy but have struggled to lose weight. I was wondering what your feeling are on using a ...

A continuous glucose monitor (CGM) can tell you when my glucose spikes, but not that I delayed correcting it because I was in a high-stakes meeting. It can record the number after I under-bolused for ...

Masimo alleged Apple used its IP to fix problems with the sensors in Apple Watches. It claimed Apple recruited key experts from Masimo and a spin-off company. Apple asked the court to limit any award ...

What just happened? Apple has been dealt a blow in its long-running patent battle against Masimo after a court ordered Cupertino to pay the health tech firm $634 million. The decision came on the same ...

In the latest chapter of the long-running legal war between Apple and medical tech company Masimo, a federal jury in California has ordered Apple to pay $634 million in damages. The jury found that ...

University Hospitals recently announced the expansion of remote patient monitoring capabilities with the goals of enhancing patient safety, improving the patient experience, and increasing operational ...

A federal jury in California has sided with Masimo in a patent battle with Apple over Apple Watch’s blood oxygen feature. The jury awarded Masimo $634 million in damages and concluded that Apple ...